In 2014, medical imaging was involved in three of four common diagnostic procedures deemed by the literature to present more risk of harm and/or unjustifiable expense than warranted by potential benefit, according to a special report published Nov. 9 in JAMA Internal Medicine.

A new study shows relative dose dangers aren’t getting communicated to patients prior to radiographic exams, and the lack owes largely to limited awareness of radiation-induced cancer risks among patients and physicians alike. 

Bayland Technologies continues to set a high standard in the refurbishing, repair and maintenance of diagnostic imaging equipment for radiologists, outpatient imaging center, and hospital radiology departments. Now, Bayland's services have grown to include repair service for LED and LCD diagnostic Radiology monitors.

Seno Medical Instruments, Inc. (Seno), the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today the presentation of case reports from the company's European MAESTRO Study, demonstrating the potential of its Imagio® opto-acoustic (OA) breast imaging system to provide physicians with vital information needed to determine whether a suspicious breast mass is cancerous or not, helping women avoid negative biopsy procedures.

A retrospective study of nearly three quarters of a million women in Germany shows that, as women age, their chances rise for having ductal carcinoma in situ (DCIS) detected in screening. 

Layering brief radiologist training sessions atop feedback-enabled dose tracking, researchers at Children’s Hospital of Pittsburgh have shown that it’s possible to cut radiation exposure to pediatric patients almost in half. 

CT scans in the emergency department (ED) often lead to key changes in clinical decisionmaking for symptoms commonly seen in ED visits, according to a study published in Radiology. 

Breast cancer treatments are improving and prognoses more positive overall, but, even at this advanced stage of the high-tech “war on cancer,” early diagnosis and staging are still of the essence.